Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Ferrol – page 3

60 clinical trials in Ferrol, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Ferrol at a glance
60
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

60 trials in Ferrol

Open in trial search

Obesity+1

Not yet recruiting

Study of Once‑Weekly Eloralintide (LY3841136 Sodium) in Adults with Obesity or Overweight, Type 2 Diabetes, and High Cardiovascular Risk

Investigational
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:LY3841136 sodium
  • Sponsor:Eli Lilly & Co.

Colitis ulcerative

Not yet recruiting

Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Colitis ulcerative

Not yet recruiting

Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Hypertension

Not recruiting

Study on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Lorundrostat
  • Sponsor:Mineralys Therapeutics Inc.

Arteriosclerosis

Not recruiting

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Crohn's disease

Not recruiting

Study on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Crohn's disease

Not recruiting

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

Type 1 diabetes mellitus+2

Not recruiting

Efficacy and Safety of Tirzepatide Versus Placebo in Adults with Type 1 Diabetes and Obesity or Overweight: A Phase 3 Randomized Controlled Trial

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tirzepatide
  • Sponsor:Eli Lilly & Co.

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dulaglutide
  • Sponsor:Eli Lilly & Co.

Obesity

Not recruiting

Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:HRS 9531

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Ferrol

What the registry says about research in the country

01 Metabolic Disorders

Clinical research focusing on innovative treatments for Type 2 Diabetes and obesity management. Studies evaluate new insulin formulations and novel therapeutic approaches for weight management.

  • Diabetes management strategies
  • Weight loss interventions
  • Metabolic health optimization

Multiple trials exploring dual-action medications targeting both obesity and associated conditions.

02 Gastrointestinal Diseases

Comprehensive research into inflammatory bowel conditions, including Ulcerative Colitis and Crohn's Disease. Studies focus on novel therapeutic agents and treatment approaches.

  • Advanced biologics testing
  • Long-term disease management
  • Pediatric treatment options

Innovative therapies being evaluated for both induction and maintenance of remission.

03 Cardiovascular Health

Studies targeting cardiovascular disease prevention and treatment, including research on stroke prevention in atrial fibrillation and atherosclerosis management.

  • Heart failure treatments
  • Stroke prevention strategies
  • Hypertension management

Focus on both preventive measures and therapeutic interventions for various cardiac conditions.

04 Renal Studies

Investigation of treatments for chronic kidney disease, including both diabetic and non-diabetic conditions. Research evaluates novel therapeutic combinations and standalone treatments.

  • Kidney disease progression
  • Combination therapy approaches
  • Albumin reduction strategies

Emphasis on delaying disease progression and improving outcomes in kidney disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.